Clinical trials
Recruiting Phase 2/3 trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
44 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 4 |
| 2025 | 19 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 44 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 7 |
| AbbVie | 5 |
| Pfizer | 4 |
| Janssen Research & Development, LLC | 3 |
| Daiichi Sankyo | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Otsuka Pharmaceutical Co., Ltd. | 2 |
| Takeda | 2 |
| Bicara Therapeutics | 1 |
| BioMarin Pharmaceutical | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 5 |
| Neoplasms | 4 |
| Lung Neoplasms | 3 |
| Attention Deficit Disorder with Hyperactivity | 2 |
| Colorectal Neoplasms | 2 |
| Stomach Neoplasms | 2 |
| Urinary Bladder Neoplasms | 2 |
| Achondroplasia | 1 |
| Anorexia | 1 |
| Atherosclerosis | 1 |
Trials
Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.